Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-037795
Filing Date
2025-08-05
Accepted
2025-08-05 16:03:30
Documents
90
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bcrx-20250630.htm   iXBRL 10-Q 1633506
2 EX-10.2 bcrx-20250630x10xqxex102.htm EX-10.2 7914
3 EX-10.3 bcrx-20250630x10xqxex103.htm EX-10.3 136019
4 EX-10.4 bcrx-20250630x10xqxex104.htm EX-10.4 17775
5 EX-31.1 bcrx-20250630x10xqxex311.htm EX-31.1 10681
6 EX-31.2 bcrx-20250630x10xqxex312.htm EX-31.2 10650
7 EX-32.1 bcrx-20250630x10xqxex321.htm EX-32.1 6040
8 EX-32.2 bcrx-20250630x10xqxex322.htm EX-32.2 5804
  Complete submission text file 0001628280-25-037795.txt   9157591

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcrx-20250630.xsd EX-101.SCH 66786
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bcrx-20250630_cal.xml EX-101.CAL 95074
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bcrx-20250630_def.xml EX-101.DEF 327386
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcrx-20250630_lab.xml EX-101.LAB 786356
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcrx-20250630_pre.xml EX-101.PRE 565657
93 EXTRACTED XBRL INSTANCE DOCUMENT bcrx-20250630_htm.xml XML 1263496
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 251184798
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)